Timing and treatment strategies according to SCAI classification in cardiogenic shock
Standard
Timing and treatment strategies according to SCAI classification in cardiogenic shock. / Tarantini, Giuseppe; Masiero, Giulia; Thiele, Holger; Iannaccone, Mario; Schrage, Benedikt; Hassager, Christian; Woitek, Felix; Chieffo, Alaide; Møller, Jacob Eifer.
In: EUR HEART J SUPPL, Vol. 25, No. Suppl I, 12.2023, p. I19-I23.Research output: SCORING: Contribution to journal › Short publication › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Timing and treatment strategies according to SCAI classification in cardiogenic shock
AU - Tarantini, Giuseppe
AU - Masiero, Giulia
AU - Thiele, Holger
AU - Iannaccone, Mario
AU - Schrage, Benedikt
AU - Hassager, Christian
AU - Woitek, Felix
AU - Chieffo, Alaide
AU - Møller, Jacob Eifer
N1 - © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.
PY - 2023/12
Y1 - 2023/12
N2 - In patients with cardiogenic shock (CS), particularly those with acute myocardial infarction (AMI), evidence suggests that timely diagnosis and treatment interventions are critical in the prevention of haemo-metabolic compromise. Temporary mechanical circulatory support (tMCS) has shown potential in facilitating revascularization and recovery of patients with acute myocardial infarction cardiogenic shock (AMI-CS). Timing of treatment strategies for CS patients needs to be optimized for use of tMCS devices that are applicable to this heterogeneous patient population. Here, the latest evidence as well as the gaps in knowledge surrounding the role of time in the management of patients with CS is summarized.
AB - In patients with cardiogenic shock (CS), particularly those with acute myocardial infarction (AMI), evidence suggests that timely diagnosis and treatment interventions are critical in the prevention of haemo-metabolic compromise. Temporary mechanical circulatory support (tMCS) has shown potential in facilitating revascularization and recovery of patients with acute myocardial infarction cardiogenic shock (AMI-CS). Timing of treatment strategies for CS patients needs to be optimized for use of tMCS devices that are applicable to this heterogeneous patient population. Here, the latest evidence as well as the gaps in knowledge surrounding the role of time in the management of patients with CS is summarized.
U2 - 10.1093/eurheartjsupp/suad129
DO - 10.1093/eurheartjsupp/suad129
M3 - Short publication
C2 - 38093764
VL - 25
SP - I19-I23
JO - EUR HEART J SUPPL
JF - EUR HEART J SUPPL
SN - 1520-765X
IS - Suppl I
ER -